Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D T Jayaweera

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2002
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039Keith Chirgwin, Richard Hafner, Catherine Leport, et al.
Gastroenterology|October 6, 2009
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidatesAruna Subramanian, Mark Sulkowski, Burc Barin, et al.
HIV Medicine|August 9, 2011
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patientsS M E Vrouenraets, F W N M Wit, E Fernandez Garcia, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2002
Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039Keith Chirgwin, Richard Hafner, Catherine Leport, et al.
Gastroenterology|October 6, 2009
MELD score is an important predictor of pretransplantation mortality in HIV-infected liver transplant candidatesAruna Subramanian, Mark Sulkowski, Burc Barin, et al.
HIV Medicine|August 9, 2011
Randomized comparison of metabolic and renal effects of saquinavir/r or atazanavir/r plus tenofovir/emtricitabine in treatment-naïve HIV-1-infected patientsS M E Vrouenraets, F W N M Wit, E Fernandez Garcia, et al.
Pageof 2